22786777

Fulghesu AM

2012

Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study.

22787248

Franks S

2012

The investigation and management of hirsutism.

22789864

Yan L

2012

Expression of apoptosis-related genes in the endometrium of polycystic ovary syndrome patients during the window of implantation.

22791704

Jia H

2013

Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with polycystic ovary syndrome: a meta-analysis.

22792101

Xiang SK

2012

Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Polycystic Ovary Syndrome.

22795636

Bhattacharya SM

2012

Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.

22798064

Younis A

2012

The relationship between pregnancy and oxidative stress markers on patients undergoing ovarian stimulations.

22798247

Li H

2013

Increased expression of P450scc and CYP17 in development of endogenous hyperandrogenism in a rat model of PCOS.

22800760

Antonson P

2012

Generation of ER?-floxed and knockout mice using the Cre/LoxP system.

22801903

Wojciechowski P

2012

Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis.

22805002

Tarantino G

2013

Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis.

22808940

Nidhi R

2013

Effects of a holistic yoga program on endocrine parameters in adolescents with polycystic ovarian syndrome: a randomized controlled trial.

22808990

Xiao J

2012

The effectiveness of metformin ovulation induction treatment in patients with PCOS: a systematic review and meta-analysis.

22809865

Baghdadi LR

2012

Impact of obesity on reproductive outcomes after ovarian ablative therapy in PCOS: a collaborative meta-analysis.

22809877

Atiomo W

2012

Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study.

22811311

Martins WP

2012

Overlooking intention-to-treat results.

22811314

Tartarin P

2012

Metformin exposure affects human and mouse fetal testicular cells.

22819571

Shalom-Paz E

2012

PCOS patients can benefit from in vitro maturation (IVM) of oocytes.

22823904

Lisi F

2012

Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study.

22824735

Veltman-Verhulst SM

2012

Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies.

22824749

Hong Y

2012

Serum visfatin is elevated in Chinese women with polycystic ovary syndrome, but might not be a reliable predictor of their glucose intolerance.

22825968

de Resende LO

2012

Single-cell expression analysis of BMP15 and GDF9 in mature oocytes and BMPR2 in cumulus cells of women with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation.

22827167

Vanky E

2012

Breast size increment during pregnancy and breastfeeding in mothers with polycystic ovary syndrome: a follow-up study of a randomised controlled trial on metformin versus placebo.

22827297

Celik ?

2013

Salusins, newly identified regulators of hemodynamics and mitogenesis, increase in polycystic ovarian syndrome.

22827740

Jones BJ

2013

In vitro fertilization treatment influences glucose tolerance in multiple pregnancy.

22829562

Randeva HS

2012

Cardiometabolic aspects of the polycystic ovary syndrome.

22829818

Moran C

2012

Obesity differentially affects phenotypes of polycystic ovary syndrome.

22830534

Stefater MA

2013

Bariatric surgery for adolescents.

22834924

Diamanti-Kandarakis E

2012

Insulin resistance and polycystic ovary syndrome through life.

22835333

Artini PG

2013

Infertility and pregnancy loss in euthyroid women with thyroid autoimmunity.

22835445

Junk SM

2012

Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome.

22835450

Lerchbaum E

2012

Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.

22837137

Zhong Y

2012

The efficacy of conversion from IUI to IVF-ET in infertility patients with hyper-response to ovulation induction: a retrospective study.

22837189

Jones H

2012

Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance.

22840935

To WW

2012

A comparison of bone mineral density in normal weight and obese adolescents with polycystic ovary syndrome.

22840936

Bonny AE

2012

Clinical variability in approaches to polycystic ovary syndrome.

22840945

Veilleux-Lemieux M

2012

Severe hyperandrogenemia and insulin resistance in a 12-year-old girl.

22844280

Koce?ak P

2012

Psychological disturbances and quality of life in obese and infertile women and men.

22846529

Catteau-Jonard S

2012

Hyperandrogenism in adolescent girls.

22846648

de Ziegler D

2012

Retrieving oocytes from small non-stimulated follicles in polycystic ovary syndrome (PCOS): in vitro maturation (IVM) is not indicated in the new GnRH antagonist era.

22847243

Ozerlat I

2012

Reproductive endocrinology: Endothelial dysfunction in women with polycystic ovary syndrome--an inherent effect?

22847851

Hatziagelaki E

2012

Insulin resistant phenotype of polycystic ovary syndrome does not seem to be caused by variation in FTO.

22849614

Aydogdu A

2013

Increase in subcutaneous adipose tissue and fat free mass in women with polycystic ovary syndrome is related to impaired insulin sensitivity.

22850474

Abdulghani M

2012

The ameliorative effects of Eurycoma longifolia Jack on testosterone-induced reproductive disorders in female rats.

22854013

Cruz G

2012

Temporal window in which exposure to estradiol permanently modifies ovarian function causing polycystic ovary morphology in rats.

22854419

Spanos N

2012

Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.

22855917

Mehrabani HH

2012

Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study.

22859292

Kandaraki E

2012

Reduced ovarian glyoxalase-I activity by dietary glycotoxins and androgen excess: a causative link to polycystic ovarian syndrome.

22863972

Armstrong AJ

2012

Diagnosis and management of endometrial hyperplasia.

22865034

Eryilmaz OG

2012

Endometrial thickness measurement throughout a menstrual cycle in non-obese infertile patients with polycystic ovary syndrome.

22865037

Gulhan I

2012

Serum Fetuin-A levels in women with polycystic ovary syndrome.

22870011

Mandrelle K

2012

Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India.

22870016

Jain M

2012

MTHFR C677T polymorphism is associated with hyperlipidemia in women with polycystic ovary syndrome.

22872544

Kreimann EL

2013

Subcellular redistribution of NHERF1 in response to dehydroepiandrosterone (DHEA) administration in endometrial glands of Wistar rats.

22873731

Kozica SL

2012

Health-related behaviors in women with lifestyle-related diseases.

22874072

Chang RJ

2013

Disordered follicle development.

22876539

Carroll J

2012

Environmental and genetic factors influence age at menarche in women with polycystic ovary syndrome.

22879630

Sathyapalan T

2012

Atorvastatin reduces malondialdehyde concentrations in patients with polycystic ovary syndrome.

22882204

Lansdown A

2012

The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?

22882325

Idali F

2012

Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome.

22882492

Bernuci MP

2013

Transitory activation of the central and ovarian norepinephrine systems during cold stress-induced polycystic ovary in rats.

22883569

Dokras A

2012

In search of the best combined oral contraceptive for treatment of polycystic ovary syndrome.

22885925

Shi Y

2012

Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.

22886405

Li Y

2012

Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism.

22888988

Panidis D

2013

Prevalence of metabolic syndrome in women with polycystic ovary syndrome.

22889864

Maier PS

2012

Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women.

22893695

Bachelot A

2012

Influence of hormonal control on LH pulsatility and secretion in women with classical congenital adrenal hyperplasia.

22898025

Stephenson AP

2012

Magnetic resonance imaging for the study of ovarian follicles in the mouse.

22898361

Aydin K

2013

Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination.

22900502

Tellechea ML

2013

Association between ?2-adrenoceptor (ADRB2) haplotypes and insulin resistance in PCOS.

22900653

Smith JW

2011

Polycystic ovary syndrome: evidence-based strategies for managing symptoms and preventing long-term sequelae.

22901781

Belaisch-Allart J

2012

[Is it possible to avoid working on weekends in an Assisted Reproductive Technology program?].

22902918

Wang Z

2012

Variants in DENND1A and LHCGR are associated with endometrioid adenocarcinoma.

22904171

Kaur S

2012

Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis.

22904174

Gonz?lez F

2012

Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome.

22905473

Sugaya S

2012

A case of polycystic ovary syndrome conceived by intracytoplasmic sperm injection following laparoscopic ovarian drilling.

22908056

Polymeris A

2012

The pluses and minuses of bariatric surgery for morbid obesity: An endocrinological perspective.

22920234

Merviel P

2012

[What is mild stimulation?].

22921077

Fleming R

2012

Interpreting human follicular recruitment and antim?llerian hormone concentrations throughout life.

22921097

Okoroh EM

2012

Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003-2008.

22921588

Nandalike K

2012

Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome.

22925367

Flannery CA

2013

Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI.

22925421

Ismail MT

2013

Preincisional infiltration and intraperitoneal instillation of levobupivacaine 0.25% for management of early postoperative pain following laparoscopic ovarian drilling.

22926838

Moll E

2012

Health-related quality of life in women with newly diagnosed polycystic ovary syndrome randomized between clomifene citrate plus metformin or clomifene citrate plus placebo.

22927929

Abbott AD

2012

Early-to-mid gestation fetal testosterone increases right hand 2D:4D finger length ratio in polycystic ovary syndrome-like monkeys.

22928702

Bredella MA

2013

Impact of metformin monotherapy versus metformin with oestrogen-progesterone on lipids in adolescent girls with polycystic ovarian syndrome.

22929762

Talib HJ

2013

Gynecologic and reproductive health concerns of adolescents using selected psychotropic medications.

22930247

Boutzios G

2013

Common pathophysiological mechanisms involved in luteal phase deficiency and polycystic ovary syndrome. Impact on fertility.

22931938

Gong CX

2012

[Studies on mechanism of polycystic ovary syndrome and the diagnosis and treatment princial for adolescents].

22932791

Du Q

2012

Effects of thiazolidinediones on polycystic ovary syndrome: a meta-analysis of randomized placebo-controlled trials.

22933528

Pinola P

2012

Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.

22934032

Fu Q

2012

Microneurographic research in women.

22934549

Hudecova M

2012

Long-term reproductive and metabolic consequences of PCOS.

22935043

R? TB

2012

Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero.

22935150

Dai G

2012

Different protein expression patterns associated with polycystic ovary syndrome in human follicular fluid during controlled ovarian hyperstimulation.

22937607

Morin-Papunen L

2012

[Treatment of infertility].

22939889

Misso ML

2012

Status of clomiphene citrate and metformin for infertility in PCOS.

22940766

Gonz?lez F

2012

Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome.

22941326

Salah IM

2013

Office microlaparoscopic ovarian drilling (OMLOD) versus conventional laparoscopic ovarian drilling (LOD) for women with polycystic ovary syndrome.

22944040

Choi YS

2012

Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-? levels in non-obese women with polycystic ovary syndrome.